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S U M M A R Y
Background: Welders are at increased risk of pulmonary infection and lobar pneumonia, likely due to
signiﬁcant occupational exposure to metal fumes. We hypothesized that welders would be at increased
risk for invasive pneumococcal disease (IPD) compared to the general population.
Methods: A retrospective chart review of all patients with IPD in the province of Alberta, Canada
(population approx. 3.3 million) was conducted from 2000 to 2004 to study the epidemiology of IPD.
Results: There were 18 cases identiﬁed in welders, giving an attack rate of 22.7 cases per 100 000
population per year (95% conﬁdence interval (CI) 12.23–33.23). Compared with an attack rate of 8.7
cases per 100 000 population per year (95% CI 8.10–9.26) for the general adult population between ages
18 and 65 years, there was a 2.7-fold greater incidence of IPD in welders (95% CI 1.67–4.22, p < 0.001).
There was an increased prevalence of serotypes 4 and 8 compared to the general population. Eight of 18
cases were caused by serotypes in the 7-valent pneumococcal conjugate vaccine, 11 of 18 cases by
serotypes in the 13-valent pneumococcal conjugate vaccine, and 18 of 18 cases by serotypes in the 23-
valent pneumococcal polysaccharide vaccine. Seventeen patients had bacteremic pneumococcal
pneumonia and one had meningitis; one person died due to infection. Fifteen of 18 patients were either
current or former smokers, which was a higher rate than the general population adjusted for age and
gender (odds ratio 2.976, 95% CI 0.908–9.729, p = 0.084).
Conclusions: Welders, particularly those who smoke, are at increased risk of IPD and should be
considered for routine administration of the pneumococcal polysaccharide vaccine. Ongoing workplace
measures to reduce exposure to metal fumes and promote smoking cessation should be reinforced.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Streptococcus pneumoniae is an important cause of community-
acquired pneumonia and bacteremia. Invasive pneumococcal
disease (IPD) is deﬁned as isolation of S. pneumoniae from a
normally sterile body site (typically blood or cerebrospinal ﬂuid),
and carries with it signiﬁcant morbidity and mortality. Numerous
risk factors for IPD have been identiﬁed, which include extremes of
age, various medical co-morbidities including congestive heart
failure and diabetes mellitus, alcohol abuse, smoking, solid-organ
or hematological transplant, and immunosuppression.1–4 Vaccina-
tion of adults with the 23-valent pneumococcal polysaccharide
vaccine offers a protective beneﬁt against IPD, and is recom-
mended for adults in high-risk groups.5,6* Corresponding author. Tel.: +780 407 8077; fax: +780 407 7137.
E-mail address: alex@ualberta.net (A. Wong).
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doi:10.1016/j.ijid.2010.02.2268In the context of a large ﬁve-year retrospective study of all
patients with IPD in the province of Alberta, we sought to clarify
the relationship between occupation and IPD, particularly in ‘high-
risk’ occupations where routine work exposures could predispose
individuals to IPD. For the purposes of our study, the occupations
considered included welding, farming, day care workers, and
electricians.
Methods
Demographics and deﬁnitions
The study encompassed the province of Alberta from 2000 to
2004, which at the time of the study was divided into nine health
regions. The provincial populationwas 2 967 755 in 2000 and 3 179
036 in 2004.7 Cases of IPD were deﬁned as the isolation of S.
pneumoniae from any normally sterile body site, including blood,
cerebrospinal ﬂuid, pleural ﬂuid, biopsy tissue, synovial ﬂuid,ses. Published by Elsevier Ltd. All rights reserved.
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a notiﬁable disease reportable to the Provincial Health Ofﬁce. S.
pneumoniae isolates recovered from patients with IPD are
submitted to the National Centre for Streptococcus (NCS) located
in Edmonton, Alberta, for capsular serotyping and antimicrobial
resistance proﬁling for trending analysis. Isolates were submitted
to the NCS prospectively from acute diagnostic microbiology
laboratories in Alberta during the study period.
To ensure as complete as possible the capture of all patientswith
IPD in Alberta during the study period, a number of databases were
utilized. These included all patients identiﬁed by identiﬁcation of S.
pneumoniae isolates sent to the NCS, all patients reported to the
ProvincialHealthOfﬁce, andallpatients captured inboththeCalgary
Area S. pneumoniae Epidemiology Research (CASPER) database
(Calgary, AB) and the Community Acquired Pneumonia Study
database (Edmonton, AB). All four databaseswere combined to form
the ﬁnal dataset, and duplicate patients were counted only once. An
extensive retrospective chart review of all identiﬁed patients was
then performed for all identiﬁed cases of IPD occurring during the
survey period. Current occupations were recorded as self-reported
by patients, including whether they were unemployed or retired.
In the laboratory, upon receipt of S. pneumoniae isolates,
bacteria were stored at 70 8C until serotyping and susceptibility
assays were performed. Only one isolate from each IPD case was
included in the review unless the isolates were collected one
month or more apart in time, or were of a different serotype if less
than one month had elapsed between episodes of IPD.
Annual incidence rates for the general population were
calculated between 2000 and 2004 using provincial population
estimates from Alberta Health and Wellness. Annual occupation-
speciﬁc incidence rates were calculated between 2000 and 2004
using provincial estimates for various occupations provided by
Alberta Employment and Immigration.
The study received approval from the institutional research
review committees of all nine health regions in Alberta and also by
the University of Alberta and the University of Calgary.
Serotyping of S. pneumoniae isolates
Isolates received at the NCS were conﬁrmed as S. pneumoniae
based onmorphology and optochin susceptibility.9 Serotypingwas
performed at the NCS by the Quellung reaction using commercial
antisera prepared at the World Health Organization (WHO)
Collaborating Center for Reference and Research on Pneumococci,
located at the Statens Serum Institut, Copenhagen, Denmark.10
Strains that failed to type were conﬁrmed as S. pneumoniae using
AccuprobeTM (Genprobe, San Diego, CA, USA).
Statistical analysis
Incidence rates and serotype prevalence were compared
between identiﬁed ‘high-risk’ occupations and the general
‘working adult’ population between the ages of 18 and 65 years
using Fisher’s exact test. All statistical analyses were performed
using SPSS version 16.0 (SPSS Inc., Chicago, IL, USA).Table 1
Rates of invasive pneumococcal disease in identiﬁed ‘at-risk’ occupations, 2000–2004.
Occupation IPD cases
2000–2004
Number employed
2000–2004, in person- years
Welder 18 79 200
Electrician 6 49 000
Farmer 7 224 700
Day care worker 8 76 500
CI, conﬁdence interval.
a Two-tailed Fisher’s exact test.Results
Incidence rates of IPD in ‘at-risk’ occupations vs. general population
A total of 1768 cases of IPD were identiﬁed in Alberta between
2000 and 2004 for which laboratory and clinical data were both
complete. Of these, 863 cases (48.8%) occurred in ‘working-age’
patients aged between 18 and 65 years, for an overall incidence
rate of 8.7 cases per 100 000 population per year (95% conﬁdence
interval (CI) 8.10–9.26). Within this group, the incidence rate in
males (9.7 cases per 100 000 population per year, 95% CI 8.87–
10.60, p < 0.001) was slightly higher than the incidence rate in
females (7.6 cases per 100 000 population per year, 95% CI 6.84–
8.38).
The incidence rates of IPD during the study period for each of
four identiﬁed ‘at-risk’ occupations are given in Table 1 and
compared with rates of IPD in the ‘working-age’ general adult
population between the ages of 18 and 65 years. A total of 18
patients with IPD (1.02%) were identiﬁed during the ﬁve-year
study period in those who reported their current occupation as
welding, for an overall occupation-speciﬁc incidence rate of 22.7
cases per 100 000 population per year (95% CI 12.23–33.23).
Compared with the remainder of the general adult population
between ages 18 and 65 years, welders had a 2.7-fold (95% CI
1.67–4.22; p < 0.0001) greater incidence of IPD. All of the
affected individuals were male, and in comparison with the
remainder of males between ages 18 and 65 years, there was
still a 2.4-fold increase (95% CI 1.50–3.81, p = 0.001) in the rate
of IPD.
Electricians (12.2 cases per 100 000 population per year, 95% CI
12.45–22.04, p = 0.329) and day care workers (10.5 cases per 100
000 population per year, 95% CI 3.21–17.70, p = 0.555) had an
increased rate of IPD compared to the remainder of the working-
age population, but neither reached statistical signiﬁcance. Farm-
ers had a lower rate of IPD (3.1 cases per 100 000 population per
year, 95% CI 0.81–5.42, p = 0.002) compared to the remainder of the
working-age population.
Demographic and clinical characteristics of welders with IPD
Selected demographic and clinical information on the IPD cases
in welders is provided in Table 2. All of the involved welders were
male, with a median age of 39 years. Thirteen (72%) were current
smokers and two (11%) were former smokers. Six reported
signiﬁcant alcohol use and four reported the use of illicit drugs.
Compared with males aged between 18 and 65 years with IPD, the
affected welders had a greater tendency to be either current or
former smokers (15/18 (83%) vs. 294/469 (63%), odds ratio (OR)
2.976, 95% CI 0.908–9.729, p = 0.084). There was no signiﬁcant
difference in rates of alcohol use between affected welders and
males aged between 18 and 65 years with IPD (159/487, 33%).
There was no pattern of medical co-morbidities identiﬁed,
although one patient had a history of recurrent upper respiratory
infection and ‘metal fume fever’, as described by the patient. There
was no geographic clustering of cases.Incidence rate/100
000/year (95% CI)
Odds ratio (95% CI) compared
to general population
p-Valuea
22.7 (12.23–33.23) 2.653 (1.670–4.215) <0.001
12.2 (2.45–22.04) 1.414 (0.646–3.093) 0.329
3.1 (0.81–5.42) 0.354 (0.171–0.732) 0.002
10.5 (3.21–17.70) 1.207 (0.610–2.389) 0.555
Table 2
Baseline characteristics of welders with invasive pneumococcal disease (N=18).
Characteristic
Median age (range in years) 39 (21–60)
Gender (male/female) 18/0
Smoker (current/former/never) 13/2/3
Signiﬁcant alcohol use 6
Illicit drug use 4
Medical co-morbidities
Hypertension 2
Hepatitis C 3
Recurrent upper respiratory infection 1
Clinical presentation
Pneumonia 16
Seizures/? encephalitis 1
Fever NYD 1
Source of isolate
Bacteremia 17
Cerebrospinal ﬂuid 1
Hospitalization
Admitted 16
ER only 1
Outpatient only 1
ICU admission 4
Mechanical ventilation 3
Tube thoracostomy 4
Mean time in hospital (days SD) 8.6311.37
Hospitalization 7 days 11
Hospitalization between 7.1 and 28 days 4
Hospitalization >28 daysH 1
Range (days) 1–43
Mean time in ICU (days SD) 9.59.68
Range (days) 1–21
In-hospital mortality 1
Results are n, unless otherwise stated.
NYD, not yet diagnosed; ER, emergency room; ICU, intensive care unit; SD, standard
deviation.
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patient had meningitis. All had radiographic changes (predomi-
nantly lobar inﬁltrates) consistent with community-acquired
pneumonia. Sixteen patients required hospital admission and of
these, four required intensive care unit (ICU) admission. Three
patients required mechanical ventilation and four patients
required tube thoracostomy for either empyema or pleural
effusion. There was a single death which occurred in the patient
with meningitis, who was admitted to an ICU and who died one
day after admission to hospital. For all patients admitted to
hospital (including the patient who died), the average length of
stay was 8.63 days (range 1–43 days), with 10 being discharged in
one week or less. For those admitted to an ICU (including the
patient who died), the average length of ICU admission was 9.5
days (range 1–21 days).
S. pneumoniae serotypes of isolates from welders with IPD
There was an increased prevalence of serotypes 4 (6/18 (33%)
vs. 121/827 (15%), OR 2.917, 95% CI 1.113–7.660, p = 0.004) and 8
(3/18 (17%) vs. 69/827 (9%), OR 2.197, 95% CI 0.666–7.289,
p = 0.193) compared with the working-age population. Two cases
were caused by serotype 7F, and one case was caused by each of
serotypes 1, 9N, 9 V, 12F, 14, 22F, and 33F. Eight cases (44%) were
caused by serotypes covered by the 7-valent conjugate vaccine
(PCV7) and 11 cases (61%) caused by serotypes covered by the 13-
valent conjugate vaccine (PCV13). All 18 cases were caused by
serotypes covered by the 23-valent polysaccharide vaccine
(PPV23).
Discussion
A signiﬁcant excess of lobar pneumonia in welders from
England and Wales in comparison with what would be expectedfrom age-speciﬁc rates in the general population was described by
Coggon et al.11 This excess risk was not observed in those above
retirement age, lending support to the existence of a reversible
occupation-speciﬁc risk factor. The chemical properties of welding
fumes are complex, and the most common elemental constituents
include iron, chromium, and nickel. Animal studies have demon-
strated that exposure to stainless steel welding fumes, which
contain large amounts of chromium and nickel, promotes lung
inﬂammation and injury.12 Chronic exposure to metal fumes
blunts the inﬂammatory response of lung tissue against inhaled
particulate matter, which may predispose to the development of
respiratory infection.13 Speciﬁcally, chromium is most likely the
primary constituent responsible for suppression of lung defense
mechanisms.14 Exposure to metal fumes has been shown to
predispose to pneumonia, with a particular association between
lobar pneumonia and recent exposure to ferrous fumes.15
Increased rates of pneumonia have been identiﬁed in other
occupations with exposure to metal fumes, such as furnace men
and foundry workers.11
During our ﬁve-year retrospective analysis (2000–2004), we
identiﬁed 18 cases of IPD in welders in the province of Alberta, a
2.7-fold increased incidence of IPD in this occupational group
compared to the general adult working population between ages
18 and 65 years. Seventeen of 18 had invasive pneumococcal
bacteremia and all patients had clinical symptoms and radio-
graphic changes consistent with pneumonia (predominantly lobar
pneumonia). Clinical outcomes were favorable in most of these
patients, but four required ICU admission and there was one death
directly attributed to IPD in a patient who developed pneumococ-
cal meningitis and who also had clinical ﬁndings compatible with
pneumonia.
Eleven of 18 cases were caused by pneumococcal serotypes
covered by PCV13 and all cases involved serotypes covered by
PPV23.We did not identify a signiﬁcant increase in IPD attack rates
in other ‘at-risk’ occupations such as electricians, farmers, and day-
care workers.
Cigarette smoking is a strong independent risk factor for IPD
in immunocompetent, non-elderly adults. In a 1995 population-
based surveillance study performed in Dallas County, Texas,
smoking was associated with a 2.6-fold increase (95% CI 1.9–3.5)
for those between the ages of 24 and 64 years.16 In a population-
based case–control study published in 2000, for those between
18 and 64 years of age with IPD, there was a 4.1-fold increase in
risk (95% CI 2.4–7.3) for those who actively smoked. There was
also evidence of a dose–response curve with respect to both
total duration of smoking and number of daily cigarettes
smoked.2
Fifteen of the 18 affected welders were either current or former
smokers (83%), which was higher than the remainder of males of
working-age in our study (OR 2.976, 95% CI 0.908–9.729,
p = 0.084), though not statistically signiﬁcant. The increased rates
of IPD in welders seen in our study may at least be partially
conferred due to smoking, but the added risk from occupational
exposure remains real. Baseline demographics on all welders in the
province (such as age and smoking rates) during the study period
were not available, which precludes further analysis to determine
the relative impact of occupational exposure and smoking on IPD
risk in this population. For comparison, rates of smoking were also
increased in affected electricians (5/6) compared to males of
working age, but not in farmers (2/7). All affected day care workers
were female, and rates of smoking in this group (4/8) were not
increased compared to the remainder of working-age females.
Currently, PPV23 is recommended for all adults aged 65 years
and in younger patients with a wide variety of medical conditions
that increase the risk of IPD.9,10 Canadian guidelines for the
administration of PPV23 would not be applicable to the signiﬁcant
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increased risk of IPD and is a logical extension of the previous
literature reporting increased lobar pneumonia in welders and
those exposed to metal fumes, most of which were presumably
caused by S. pneumoniae. Consideration should be given to the
routine administration of PPV23 in all welders, and the profession
as a whole should be made aware of the increased risk of
pneumonia and invasive disease. Ongoing workplace measures to
reduce exposure to metal fumes should be encouraged.
There are limitationswith our study.We only captured patients
with a positive isolate, and it is possible that cases of IPD were
missed if cultures were not done or if they were negative (e.g., if
drawn after the administration of antibiotics). We relied on
documentation of occupation on the patient charts, and it is
possible that cases were missed because occupation was not
documented. Our study thus provides a minimal estimate of the
risk of IPD in different occupations and the actual risk may be
higher. A higher proportion of affected welders in our study were
either current or former smokers when compared to the affected
general population adjusted for age and gender, which suggests
that some of the increased risk of IPD in welders seen in our study
may be attributable to smoking rather than occupational exposure.
Although the presence of co-morbidities amongst affected welders
was minimal, there could have been other confounding factors not
accounted for in this study.
In summary, our data demonstrate thatwelders are at increased
risk of IPD, particularly those who smoke. Consideration should be
given to pneumococcal vaccination in all members of this
occupation, and the importance of smoking cessation should be
reinforced. Those in the profession, especially those who smoke,
should be made aware of the increased risk of pneumonia and
invasive disease and the potential beneﬁts of vaccination.
Workplace measures to reduce exposure to metal fumes and
encourage smoking cessation should be encouraged and actively
monitored.
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